GLP-1 Receptor Agonist Market Forecast 2026–2036: Market to Reach USD 7.9 Billion by 2036 at 11.7% CAGR
Rising prevalence of Type 2 Diabetes and obesity fuels strong growth in the GLP-1 Receptor Agonist Market. ROCKVILLE, MD, UNITED STATES, March 18, 2026 /EINPresswire.com/ -- The global pharmaceutical landscape is currently witnessing its most …